FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949867514> ?p ?o ?g. }

• W2949867514 endingPage "e1466" @default.
• W2949867514 startingPage "e1460" @default.
• W2949867514 abstract "Abstract Background The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scale is commonly used by physicians and nurses in oncology, as it correlates with cancer morbidity, mortality, and complications from chemotherapy and can help direct clinical decisions and prognostication. This retrospective cohort study aimed to identify whether ECOG-PS scores rated by oncologist versus nurses differ in their ability to predict clinical outcomes. Materials and Methods Over 19 months, 32 oncologists and 41 chemotherapy nurses from a single academic comprehensive cancer center independently scored ECOG-PS (range: 0–5) for a random sample of 311 patients with cancer receiving chemotherapy. Logistic regression models were fit to evaluate the ability of nurse and physician ECOG-PS scores, as well as the nurse-physician ECOG-PS score difference (nurse minus physician), to predict the occurrence of chemotherapy toxicity (CTCAE v4, grade ≥3) and hospitalizations within 1 month from ECOG-PS ratings, as well as 6-month mortality or hospice referrals. Results Physician/nurse ECOG-PS agreement was 71% (Cohen's κ = 0.486, p &lt; .0001). Nurse ECOG-PS scores had stronger odds ratio for 6-month mortality or hospice (odds ratio [OR], 3.29, p &lt; .0001) than physician ECOG-PS scores (OR, 2.71, p = .001). Furthermore, ECOG-PS ratings by nurses, but not physicians, correlated with 1-month chemotherapy toxicity (OR, 1.44, p = .021) and 1-month hospitalizations (OR, 1.57, p = .041). Nurse-physician disagreement, but only when physicians gave “healthier” (lower) ratings, was also associated with worse outcomes (chemotherapy toxicity OR = 1.51, p = .045; 1-month hospitalization OR, 1.86, p = .037; 6-month mortality or hospice OR, 2.99, p &lt; .0001). Conclusion Nurse ECOG-PS ratings seem more predictive of important outcomes than those of physicians, and physician-nurse disagreement in ECOG-PS ratings predicts worse outcomes; scoring by nurses may result in additional clinical benefit. Implications for Practice Nurse-rated Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores, compared with those rated by oncologists, better predicted hospitalizations and severe chemotherapy toxicity within 1 month from ECOG-PS assessment, as well as mortality or hospice referrals within 6 months. Physician-nurse disagreement in ECOG-PS scoring was associated with worse hospitalization, chemotherapy toxicity, and mortality and hospice referral rates. Rating performance statuses of patients with cancer by nurses instead or in addition to oncologists can result in additional clinical benefits, such as improved prognostication, as well as better informed clinical decision making regarding whether or not to administer chemotherapy, the need for additional supportive care, and goals of care discussions." @default.
• W2949867514 created "2019-06-27" @default.
• W2949867514 creator A5002289512 @default.
• W2949867514 creator A5024750927 @default.
• W2949867514 creator A5027630636 @default.
• W2949867514 creator A5034816464 @default.
• W2949867514 creator A5046103656 @default.
• W2949867514 creator A5050649350 @default.
• W2949867514 creator A5081040315 @default.
• W2949867514 date "2019-06-21" @default.
• W2949867514 modified "2023-10-16" @default.
• W2949867514 title "Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer" @default.
• W2949867514 cites W1254340589 @default.
• W2949867514 cites W1965380313 @default.
• W2949867514 cites W1981227632 @default.
• W2949867514 cites W1994769053 @default.
• W2949867514 cites W2011597259 @default.
• W2949867514 cites W2025904098 @default.
• W2949867514 cites W2029211011 @default.
• W2949867514 cites W2052450626 @default.
• W2949867514 cites W2075989132 @default.
• W2949867514 cites W2076668534 @default.
• W2949867514 cites W2101472517 @default.
• W2949867514 cites W2111561092 @default.
• W2949867514 cites W2113774168 @default.
• W2949867514 cites W2114543855 @default.
• W2949867514 cites W2118065062 @default.
• W2949867514 cites W2131076472 @default.
• W2949867514 cites W2146295639 @default.
• W2949867514 cites W2232913710 @default.
• W2949867514 cites W2297171155 @default.
• W2949867514 cites W2337963257 @default.
• W2949867514 cites W2590038587 @default.
• W2949867514 cites W2620925856 @default.
• W2949867514 cites W2767880786 @default.
• W2949867514 cites W2889626138 @default.
• W2949867514 cites W2891095732 @default.
• W2949867514 cites W4234655265 @default.
• W2949867514 doi "https://doi.org/10.1634/theoncologist.2018-0882" @default.
• W2949867514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6975959" @default.
• W2949867514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31227648" @default.
• W2949867514 hasPublicationYear "2019" @default.
• W2949867514 type Work @default.
• W2949867514 sameAs 2949867514 @default.
• W2949867514 citedByCount "36" @default.
• W2949867514 countsByYear W29498675142020 @default.
• W2949867514 countsByYear W29498675142021 @default.
• W2949867514 countsByYear W29498675142022 @default.
• W2949867514 countsByYear W29498675142023 @default.
• W2949867514 crossrefType "journal-article" @default.
• W2949867514 hasAuthorship W2949867514A5002289512 @default.
• W2949867514 hasAuthorship W2949867514A5024750927 @default.
• W2949867514 hasAuthorship W2949867514A5027630636 @default.
• W2949867514 hasAuthorship W2949867514A5034816464 @default.
• W2949867514 hasAuthorship W2949867514A5046103656 @default.
• W2949867514 hasAuthorship W2949867514A5050649350 @default.
• W2949867514 hasAuthorship W2949867514A5081040315 @default.
• W2949867514 hasBestOaLocation W29498675141 @default.
• W2949867514 hasConcept C113616995 @default.
• W2949867514 hasConcept C114200698 @default.
• W2949867514 hasConcept C121608353 @default.
• W2949867514 hasConcept C126322002 @default.
• W2949867514 hasConcept C143998085 @default.
• W2949867514 hasConcept C151956035 @default.
• W2949867514 hasConcept C156957248 @default.
• W2949867514 hasConcept C159110408 @default.
• W2949867514 hasConcept C167135981 @default.
• W2949867514 hasConcept C2776694085 @default.
• W2949867514 hasConcept C2776907518 @default.
• W2949867514 hasConcept C71924100 @default.
• W2949867514 hasConcept C72563966 @default.
• W2949867514 hasConceptScore W2949867514C113616995 @default.
• W2949867514 hasConceptScore W2949867514C114200698 @default.
• W2949867514 hasConceptScore W2949867514C121608353 @default.
• W2949867514 hasConceptScore W2949867514C126322002 @default.
• W2949867514 hasConceptScore W2949867514C143998085 @default.
• W2949867514 hasConceptScore W2949867514C151956035 @default.
• W2949867514 hasConceptScore W2949867514C156957248 @default.
• W2949867514 hasConceptScore W2949867514C159110408 @default.
• W2949867514 hasConceptScore W2949867514C167135981 @default.
• W2949867514 hasConceptScore W2949867514C2776694085 @default.
• W2949867514 hasConceptScore W2949867514C2776907518 @default.
• W2949867514 hasConceptScore W2949867514C71924100 @default.
• W2949867514 hasConceptScore W2949867514C72563966 @default.
• W2949867514 hasIssue "12" @default.
• W2949867514 hasLocation W29498675141 @default.
• W2949867514 hasLocation W29498675142 @default.
• W2949867514 hasLocation W29498675143 @default.
• W2949867514 hasLocation W29498675144 @default.
• W2949867514 hasOpenAccess W2949867514 @default.
• W2949867514 hasPrimaryLocation W29498675141 @default.
• W2949867514 hasRelatedWork W2013653877 @default.
• W2949867514 hasRelatedWork W2028195960 @default.
• W2949867514 hasRelatedWork W2077295477 @default.
• W2949867514 hasRelatedWork W2083380490 @default.
• W2949867514 hasRelatedWork W2969962500 @default.
• W2949867514 hasRelatedWork W2999943460 @default.
• W2949867514 hasRelatedWork W3083654737 @default.

• next